Multi-disciplinary team seeks to better understand mechanisms of radiation therapy
Top Abstracts from ASCO 2022
Our oncologists have compiled the top 10 abstracts recently presented at the annual meeting of the
American Society of Clinical Oncology.
Combination Chemo-Immunotherapy Appears to Improve Outcomes in Muscle-Invasive Bladder Cancer
New research reinforces the safety and efficacy of combination treatment with nivolumab, gemcitabine and cisplatin in patients with muscle-invasive bladder cancer.
Socioeconomic Disadvantage Is Associated With Increased Mortality After Radical Cystectomy
A new study found higher rates of mortality and worse oncologic outcomes in bladder cancer patients residing in more socioeconomically disadvantaged neighborhoods who underwent radical cystectomy.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
New Study Highlights Prescribing Patterns in the Treatment of Advanced Urothelial Carcinoma
Prescribing patterns show that an increasing number of patients with locally advanced or metastatic urothelial carcinoma are being treated with systemic therapy.
Tumor Mutational Burden May Help Guide Treatment of Metastatic Urothelial Carcinoma
Tumor mutational burden may help predict the response to immune checkpoint inhibitors in patients with metastatic urothelial carcinoma who are ineligible for chemotherapy.
Improving Outcomes and Expanding Options for Patients With Bladder Cancer
Cleveland Clinic surgeons are utilizing minimally invasive techniques and investigating new approaches to improve bladder cancer outcomes.
What Is the Role of Neoadjuvant Chemotherapy in Bladder Cancer With Variant Histology?
Findings from a new study help clarify the role of neoadjuvant chemotherapy in the management of bladder cancer with variant histology.
New Blood Test Detects Multiple Cancer Types with High Accuracy
A prototype blood-based screening test evaluated by Cleveland Clinic researchers and others can accurately detect and localize multiple types of cancer, often before symptoms show. The promising results raise hopes that the assay will help achieve the long-sought goal of population-scale early detection of cancer.
BCG Shortages Affect Bladder Cancer Care Decisions
A new Cleveland Clinic study documents the impacts that shortages of the immunotherapy agent Bacillus Calmette-Guerin have had on clinical management of non-muscle invasive bladder cancer. Urologic oncologist Robert Abouassaly, MD, discusses the findings and implications.